L
Lexaria Bioscience Corp D
D
LEXX
0.99290
USD
-0.02
(-2.18%)
مغلق
حجم التداول
134
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
19,420,309
العنوان: Lexaria Bioscience Corp
القطاع: Healthcare
الصناعة: Biotechnology
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.